MSJSX
Price
$21.39
Change
+$0.69 (+3.33%)
Updated
Jun 11 closing price
Net Assets
15.17M
RSLEX
Price
$81.65
Change
+$2.82 (+3.58%)
Updated
Jun 11 closing price
Net Assets
91.47B
Interact to see
Advertisement

MSJSX vs RSLEX

Header iconMSJSX vs RSLEX Comparison
Open Charts MSJSX vs RSLEXBanner chart's image
MSJSX vs RSLEX Comparison Chart in %
View a ticker or compare two or three
VS
MSJSX vs. RSLEX commentary
Jun 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSJSX is a Buy and RSLEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLEX has more cash in the bank: 91.5B vs. MSJSX (15.2M). RSLEX pays higher dividends than MSJSX: RSLEX (0.65) vs MSJSX (0.58). MSJSX was incepted earlier than RSLEX: MSJSX (7 years) vs RSLEX (24 years). MSJSX (8.78) is less costly to investors than RSLEX (1.00). MSJSX is a more actively managed with annual turnover of: 176.00 vs. RSLEX (41.00). RSLEX has a lower initial minimum investment than MSJSX: RSLEX (250) vs MSJSX (5000000). RSLEX annual gain was more profitable for investors over the last year : 17.58 vs. MSJSX (14.27). RSLEX return over 5 years is better than : -5.00 vs. MSJSX (-38.58).
MSJSXRSLEXMSJSX / RSLEX
Total Expense Ratio0.951.0095%
Annual Report Gross Expense Ratio8.781.00878%
Fund Existence7 years24 years-
Gain YTD-0.33712.450-3%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets15.2M91.5B0%
Annual Yield % from dividends0.580.6591%
Returns for 1 year14.2717.5881%
Returns for 3 years44.4435.84124%
Returns for 5 years-38.58-5.00772%
Returns for 10 yearsN/A93.41-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DALVX23.24N/A
N/A
Dunham Large Cap Value A
IHSUX33.90N/A
N/A
Hartford Small Company R5
TEMLX11.57N/A
N/A
Nuveen Emerging Markets Eq R6
FAPLX14.05N/A
N/A
Fidelity Advisor Healthy Future M
TGIHX15.50N/A
N/A
Nuveen Core Equity I